A carregar...
Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
BACKGROUND: The STREAM trial demonstrated that a 9–11-month “short” regimen had non-inferior efficacy and comparable safety to a 20+ month “long” regimen for the treatment of rifampicin-resistant tuberculosis. Imbalance in the components of the composite primary outcome merited further investigation...
Na minha lista:
| Publicado no: | BMC Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640464/ https://ncbi.nlm.nih.gov/pubmed/33143704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-020-01770-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|